Insight into the role of HSPG in the cellular uptake of apolipoprotein E-derived peptide micelles and liposomes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 12, 2008, Pages 2781-2789

  Leupold, Eik ^a   Nikolenko, Heike ^a   Beyermann, Michael ^a   Dathe, Margitta ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Apolipoprotein E; Cell penetrating peptide; Cellular uptake; Endocytosis; HSPG; Peptide micelles; Peptide liposome complex

Indexed keywords

AMINO ACID; APOLIPOPROTEIN E; CARBOXYFLUORESCEIN; LIPOSOME; PEPTIDE; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CONFOCAL LASER MICROSCOPY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; INTERNALIZATION; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN TRANSPORT;

ANIMALS; APOLIPOPROTEINS E; BRAIN; CAPILLARIES; CELL LINE, TRANSFORMED; CELLS, CULTURED; ENDOCYTOSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEPARAN SULFATE PROTEOGLYCANS; LIPOSOMES; MICE; MICELLES; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 55749083692     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.09.008     Document Type: Article

References (60)

1. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
2. Maurer N., Fenske D.B., and Cullis P.R. Developments in liposomal drug delivery systems. Expert Opin. Biol. Ther. 1 (2001) 923-947
3. Torchilin V.P., Lukyanov A.N., Gao Z., and Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6039-6044
4. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
5. Voinea M., Dragomir E., Manduteanu I., and Simionescu M. Binding and uptake of transferrin-bound liposomes targeted to transferrin receptors of endothelial cells. Vascul. Pharmacol. 39 (2002) 13-20
6. Begley D.J. The blood brain barrier: principles for targeting peptides and drugs to the central nervous system. J. Pharm. Pharmacol. 48 (1996) 136-146
7. Cerletti A., Drewe J., Fricker G., Eberle A.N., and Huwyler J. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J. Drug Target 8 (2000) 435-446
8. Liu L., Guo K., Lu J., Venkatraman S.S., Luo D., Ng K.C., Ling E.A., Moochhala S., and Yang Y.Y. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 29 (2008) 1509-1517
9. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
10. Lucarelli M., Gennarelli M., Cardelli P., Novelli G., Scarpa S., Dallapiccola B., and Strom R. Expression of receptors for native and chemically modified low-density lipoproteins in brain microvessels. FEBS Lett. 401 (1997) 53-58
11. Rensen P.C., de Vrueh R.L., Kuiper J., Bijsterbosch M.K., Biessen E.A., and van Berkel T.J. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv. Drug Deliv. Rev. 47 (2001) 251-276
12. Datta G., Garber D.W., Chung B.H., Chaddha M., Dashti N., Bradley W.A., Gianturco S.H., and Anantharamaiah G.M. Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo. J. Lipid Res. 42 (2001) 959-966
13. Dyer C.A., and Curtiss L.K. A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J. Biol. Chem. 266 (1991) 22803-22806
14. Sauer I., Dunay I.R., Weisgraber K., Bienert M., and Dathe M. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells. Biochemistry 44 (2005) 2021-2029
15. Sauer I., Nikolenko H., Keller S., Abu Ajaj K., Bienert M., and Dathe M. Dipalmitoylation of a cellular uptake-mediating apolipoprotein E-derived peptide as a promising modification for stable anchorage in liposomal drug carriers. Biochimica et Biophysica Acta 1758 (2006) 552-561
16. Keller S., Sauer I., Strauss H., Gast K., Dathe M., and Bienert M. Membrane-mimetic nanocarriers formed by a dipalmitoylated cell-penetrating peptide. Angew. Chem. Int. Ed. Engl. 44 (2005) 5252-5255
17. Dathe M., Keller S., Sauer I., and Bienert M. Cellular uptake of liposomal and micellar carriers mediated by ApoE-derived peptides. In: Langel U. (Ed). Handbook of Cell-Penetrating Peptides. Second Edition (2006), CRC Press 483-503
18. Cardin A.D., and Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9 (1989) 21-32
19. Weisgraber K.H., Rall Jr. S.C., Mahley R.W., Milne R.W., Marcel Y.L., and Sparrow J.T. Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J. Biol. Chem. 261 (1986) 2068-2076
20. Mahley R.W., and Ji Z.S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40 (1999) 1-16
21. Datta G., Chaddha M., Garber D.W., Chung B.H., Tytler E.M., Dashti N., Bradley W.A., Gianturco S.H., and Anantharamaiah G.M. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts. Biochemistry 39 (2000) 213-220
22. Belting M. Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28 (2003) 145-151
23. Belting M., Wittrup A., and Sandgren S. Proteoglycans as endocytosis receptors for CPPs. In: Langel U. (Ed). Handbook of Cell-Penetrating Peptides. Second Edition (2006), CRC Press 219-234
24. Poon G.M., and Gariepy J. Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem. Soc. Trans. 35 (2007) 788-793
25. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., and Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280 (2005) 15300-15306
26. Ziegler A., Nervi P., Durrenberger M., and Seelig J. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44 (2005) 138-148
27. Tyagi M., Rusnati M., Presta M., and Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276 (2001) 3254-3261
28. Marty C., Meylan C., Schott H., Ballmer-Hofer K., and Schwendener R.A. Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes. Cell Mol. Life Sci. 61 (2004) 1785-1794
29. Console S., Marty C., Garcia-Echeverria C., Schwendener R., and Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278 (2003) 35109-35114
30. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., and Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277 (2002) 2437-2443
31. Fuchs S.M., and Raines R.T. Pathway for polyarginine entry into mammalian cells. Biochemistry 43 (2004) 2438-2444
32. Rousselle C., Clair P., Temsamani J., and Scherrmann J.M. Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy. J. Drug Target 10 (2002) 309-315
33. Thole M., Nobmanna S., Huwyler J., Bartmann A., and Fricker G. Uptake of cationzied albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries. J. Drug Target 10 (2002) 337-344
34. Gupta B., Levchenko T.S., and Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 57 (2005) 637-651
35. Mae M., and Langel U. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr. Opin. Pharmacol. 6 (2006) 509-514
36. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
37. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., and Brock R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8 (2007) 848-866
38. Tunnemann G., Martin R.M., Haupt S., Patsch C., Edenhofer F., and Cardoso M.C. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. Faseb. J. 20 (2006) 1775-1784
39. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
40. Oehlke J., Scheller A., Wiesner B., Krause E., Beyermann M., Klauschenz E., Melzig M., and Bienert M. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414 (1998) 127-139
41. Khalil I.A., Kogure K., Futaki S., and Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 281 (2006) 3544-3551
42. Kawamura K.S., Sung M., Bolewska-Pedyczak E., and Gariepy J. Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells. Biochemistry 45 (2006) 1116-1127
43. Coin I., Beyermann M., and Bienert M. Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nat. Protoc. 2 (2007) 3247-3256
44. Omidi Y., Campbell L., Barar J., Connell D., Akhtar S., and Gumbleton M. Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res. 990 (2003) 95-112
45. Van Amersfoort E.S., and Van Strijp J.A. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 17 (1994) 294-301
46. Maxfield F.R., and McGraw T.E. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5 (2004) 121-132
47. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
48. Nakase I., Tadokoro A., Kawabata N., Takeuchi T., Katoh H., Hiramoto K., Negishi M., Nomizu M., Sugiura Y., and Futaki S. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 46 (2007) 492-501
49. Maiolo J.R., Ferrer M., and Ottinger E.A. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim. Biophys. Acta 1712 (2005) 161-172
50. Futamura M., Dhanasekaran P., Handa T., Phillips M.C., Lund-Katz S., and Saito H. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. J. Biol. Chem. 280 (2005) 5414-5422
51. Torchilin V.P., Rammohan R., Weissig V., and Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8786-8791
52. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 245 (2002) 1-7
53. Deshayes S., Decaffmeyer M., Brasseur R., and Thomas A. Structural polymorphism of two CPP: an important parameter of activity. Biochim. Biophys. Acta. 1778 (2008) 1197-1205
54. Khalil I.A., Futaki S., Niwa M., Baba Y., Kaji N., Kamiya H., and Harashima H. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther. 11 (2004) 636-644
55. Silhol M., Tyagi M., Giacca M., Lebleu B., and Vives E. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269 (2002) 494-501
56. Croy J.E., Brandon T., and Komives E.A. Two apolipoprotein E mimetic peptides, ApoE(130-149) and ApoE(141-155)2, bind to LRP1. Biochemistry 43 (2004) 7328-7335
57. Tolar M., Marques M.A., Harmony J.A., and Crutcher K.A. Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neurosci. 17 (1997) 5678-5686
58. Wang X., Ciraolo G., Morris R., and Gruenstein E. Identification of a neuronal endocytic pathway activated by an apolipoprotein E (apoE) receptor binding peptide. Brain Res. 778 (1997) 6-15
59. Fretz M.M., Penning N.A., Al-Taei S., Futaki S., Takeuchi T., Nakase I., Storm G., and Jones A.T. Temperature-, concentration-and cholesterol-dependent translocation of L-and D-octa-arginine across the plasma and nuclear membrane of CD34+leukaemia cells. Biochem. J. 403 (2007) 335-342
60. Libeu C.P., Lund-Katz S., Phillips M.C., Wehrli S., Hernaiz M.J., Capila I., Linhardt R.J., Raffai R.L., Newhouse Y.M., Zhou F., and Weisgraber K.H. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J. Biol. Chem. 276 (2001) 39138-39144